Identifying patients who will not reachieve remission after breakthrough seizures

Hughes, David M ORCID: 0000-0002-1287-9994, Bonnett, Laura J ORCID: 0000-0002-6981-9212, Marson, Anthony G ORCID: 0000-0002-6861-8806 and Garcia-Finana, Marta ORCID: 0000-0003-4939-0575 (2019) Identifying patients who will not reachieve remission after breakthrough seizures. EPILEPSIA, 60 (4). pp. 774-782.

Access the full-text of this item by clicking on the Open Access link.

Text Hughesetal_Epilepsia_cleanversion.docx - Author Accepted Manuscript Download (78kB)

Abstract

Objective We aim to identify people with epilepsy who are unlikely to reachieve a 12‐month remission within 2 years after experiencing a breakthrough seizure following an initial 12‐month remission. Methods We apply a novel longitudinal discriminant approach to data from the Standard and New Antiepileptic Drugs study to dynamically predict the risk of a patient not achieving a second remission after a breakthrough seizure by combining both baseline covariates (collected at the time of breakthrough seizure) and follow‐up data. Results The model classifies 83% of patients. Of these, 73% of patients (95% confidence interval [CI ] = 58%‐88%) who did not achieve a second remission were correctly identified (sensitivity), and 84% of patients (95% CI = 69%‐96%) who achieved a second remission were correctly identified (specificity). The area under the curve from our model was 87% (95% CI = 80%‐94%). Patients who did not achieve a second remission were correctly identified on average after 10 months of observation postbreakthrough. Occurrence of seizures after breakthrough and the number of seizures experienced were the most informative longitudinal variables. These longitudinal profiles were influenced by the following baseline covariates: age at breakthrough seizure, presence of neurological insult, and number of antiepileptic drugs required to achieve first remission. Significance Using longitudinal data gathered during patient follow‐up allows more accurate predictions than using baseline covariates in a standard Cox model. The model developed in this paper is a useful first step in developing a tool for identifying patients who develop drug resistance after an initial remission.

Item Type:	Article
Uncontrolled Keywords:	breakthrough, dynamic classification, epilepsy, focal, generalized, remission
Depositing User:	Symplectic Admin
Date Deposited:	28 Mar 2019 10:49
Last Modified:	19 Jan 2023 00:55
DOI:	10.1111/epi.14697
Open Access URL:	https://doi.org/10.1111/epi.14697
Related URLs:	Author Publisher
URI:	https://livrepository.liverpool.ac.uk/id/eprint/3035199